C19Survey: The Psychological, Social, and Economic Impacts of COVID-19

Sponsor
University of Ottawa (Other)
Overall Status
Unknown status
CT.gov ID
NCT04369690
Collaborator
Hopital du Sacre-Coeur de Montreal (Other), Sunnybrook Health Sciences Centre (Other), Southlake Regional Health Centre (Other), The Ottawa Hospital Research Institute (Other), Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal (Other), Centre for Addiction and Mental Health (Other), CHEO Research Institute (Other), Ottawa Heart Institute Research Corporation (Other), McGill University (Other), Johns Hopkins University (Other), Université de Montréal (Other), The Royal's Institute of Mental Health Research (Other)
1,000
10
12
100
8.3

Study Details

Study Description

Brief Summary

A dynamic analytical tool is being implemented to monitor the health, psychosocial and economic impacts of the COVID-19 pandemic as the crisis unfolds. A longitudinal survey is distributed via a network of hospitals, provincial/national organizations and web platforms. The survey information can be linked to provincial health administrative data and metrics derived from social media activity based on artificial intelligence methods. Targeted questions are included for critical populations such as healthcare workers and people with chronic illnesses.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The current situation unfolding with regards to the COVID-19 virus is changing core aspects of people's lives in a unique manner. This study aims to examine the psychological, social, and financial impacts of the COVID-19 pandemic at various stages of the outbreak.

    Individuals 12 years and older are recruited from three main groups: general population, people with chronic illnesses and healthcare professionals.

    An online survey is distributed via multiple hospitals, provincial/national organizations, and web-based platforms at various phases of the outbreak. The survey includes validated questionnaires and custom-made questions to asses the current situation. It notably addresses the following themes: demographics, COVID-19 symptoms and diagnoses, social distancing practices and social interactions, living situation, financial situation, family and work-related challenges, access to healthcare, as well as sleep, physical and mental health.

    The survey is available in English and French. It is built on a decisional tree structure with customized subsets of questions based on previous answers.The survey contains an adolescent version and an adult version, and also includes targeted questions for individuals with a current diagnosis of a mental/medical illness. Consent is also sought to link data from parent-child dyads to enable finer analyses of family dynamics. Healthcare staff are invited to answer questions about work-related difficulties, usefulness of virtual tools for clinical practice, as well as moral distress and moral resilience in the context of clinical practice. Healthcare staff who are short on time can chose fill out an abbreviated version. Participants have the option of enabling linkage to linked to provincial health administrative data, and to provide their twitter and facebook handle for social media and mood monitoring through artificial intelligence algorithms. Participants have the option of being followed longitudinally during and after the outbreak.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    How Are You Coping? Assessing the Psychological, Social, and Economic Impacts of an Emerging Pandemic
    Actual Study Start Date :
    Apr 3, 2020
    Anticipated Primary Completion Date :
    Apr 3, 2021
    Anticipated Study Completion Date :
    Apr 3, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Mental health - Stress [through study completion, estimated to 8 months]

      Cohen's Perceived Stress Scale (scores ranged from 0 to 40, higher scores indicating worse stress)

    2. Mental health - Anxiety [through study completion, estimated to 8 months]

      Generalized Anxiety Disorder Scale (scores ranged from 0 to 21, higher scores indicating worse anxiety)

    3. Mental health - Depression [through study completion, estimated to 8 months]

      Quick Inventory of Depressive Symptomatology-Self-report, short version (scores ranged from 0 to 27, higher scores indicating worse depression)

    Secondary Outcome Measures

    1. Moral distress in healthcare workers [through study completion, estimated to 8 months]

      Measure of Moral Distress - Healthcare Professionals (scores ranged from 0 to 432, higher scores indicating worse moral distress)

    2. Moral resilience in healthcare workers [through study completion, estimated to 8 months]

      Rushton Moral Resilience Scale (scores ranged from 1 to 4, higher scores indicating more resiliency)

    3. Social life [through study completion, estimated to 8 months]

      Frequency of interacting with other people (daily, weekly, monthly, less often than monthly)

    4. COVID-9 symptoms [through study completion, estimated to 8 months]

      Fever, Cough, Difficulty breathing or shortness of breath, Tiredness, Aches and pains, Nasal congestion, Runny nose, Sore throat, Diarrhea (Mild Moderate, Severe, N/A)

    5. Adverse health long-term outcome [5 years before the outbreak and two years after]

      Mortality (Yes/No): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx

    6. Health care utilization - Inpatient [5 years before the outbreak and two years after]

      Hospitalizations (total number): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx

    7. Health care utilization - ER [5 years before the outbreak and two years after]

      Emergency Department visits (Total number): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx

    8. Health care utilization - Outpatient [5 years before the outbreak and two years after]

      Outpatient visits: https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx

    9. Sleep [through study completion, estimated to 8 months]

      Pittsburgh Sleep Quality Index (scores ranged from 0 to 21, higher scores indicating worse sleep disturbances)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • All individuals who are at least 12 years of age
    Exclusion Criteria:
    • None

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Southlake Regional Health Centre Newmarket Ontario Canada L3Y 2P9
    2 CHEO Research Institute Ottawa Ontario Canada K1H 5B2
    3 The Ottawa Hospital Research Institute Ottawa Ontario Canada K1H 8L6
    4 The Centre for Addiction and Mental Health Ottawa Ontario Canada K1S 1V7
    5 The University of Ottawa Heart Institute Ottawa Ontario Canada K1Y 4W7
    6 The Royal's Institute of Mental Health Research Ottawa Ontario Canada K1Z 7K4
    7 Sunnybrook Health Sciences Centre Toronto Ontario Canada M4N 3M5
    8 Hôpital en santé mentale Rivière-des-Prairies (CIUSSS du Nord-de-l'Île-de-Montréal) Montréal Quebec Canada H1E 1A4
    9 McGill University Montréal Quebec Canada H3A 0G4
    10 University of Montréal Montréal Quebec Canada H3T 1J4

    Sponsors and Collaborators

    • University of Ottawa
    • Hopital du Sacre-Coeur de Montreal
    • Sunnybrook Health Sciences Centre
    • Southlake Regional Health Centre
    • The Ottawa Hospital Research Institute
    • Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
    • Centre for Addiction and Mental Health
    • CHEO Research Institute
    • Ottawa Heart Institute Research Corporation
    • McGill University
    • Johns Hopkins University
    • Université de Montréal
    • The Royal's Institute of Mental Health Research

    Investigators

    • Principal Investigator: Rébecca Robillard, PhD, University of Ottawa

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Rébecca Robillard, Dr. Rebecca Robillard, University of Ottawa
    ClinicalTrials.gov Identifier:
    NCT04369690
    Other Study ID Numbers:
    • 2131
    First Posted:
    Apr 30, 2020
    Last Update Posted:
    Apr 30, 2020
    Last Verified:
    Apr 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Rébecca Robillard, Dr. Rebecca Robillard, University of Ottawa
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 30, 2020